Siah2-dependent concerted activity of HIF and FoxA2 regulates formation of neuroendocrine phenotype and neuroendocrine prostate tumors
about
Six novel susceptibility Loci for early-onset androgenetic alopecia and their unexpected association with common diseasesEvaluation of protein biomarkers of prostate cancer aggressivenessIdentification of CBX3 and ABCA5 as putative biomarkers for tumor stem cells in osteosarcomaUSP13 enzyme regulates Siah2 ligase stability and activity via noncatalytic ubiquitin-binding domainsThe E3 ubiquitin ligase Siah2 contributes to castration-resistant prostate cancer by regulation of androgen receptor transcriptional activityHypoxia-inducible factors and the response to hypoxic stressNeuroendocrine differentiation in prostate cancer: a mechanism of radioresistance and treatment failureThe many faces of neuroendocrine differentiation in prostate cancer progressionGenetically engineered mouse models of prostate cancerStructure-Based Design of Covalent Siah InhibitorsTouch and go: nuclear proteolysis in the regulation of metabolic genes and cancerProstate Cancer: Epigenetic Alterations, Risk Factors, and TherapyA TRIP230-retinoblastoma protein complex regulates hypoxia-inducible factor-1α-mediated transcription and cancer cell invasionFine tuning of the UPR by the ubiquitin ligases Siah1/2.HES6 drives a critical AR transcriptional programme to induce castration-resistant prostate cancer through activation of an E2F1-mediated cell cycle network.The histone demethylase JMJD1A induces cell migration and invasion by up-regulating the expression of the long noncoding RNA MALAT1Mouse models of prostate cancer: picking the best model for the question.Investigating the molecular basis of Siah1 and Siah2 E3 ubiquitin ligase substrate specificity.Molecular pathways and targets in prostate cancerTissue injury and hypoxia promote malignant progression of prostate cancer by inducing CXCL13 expression in tumor myofibroblasts.Seven In Absentia Homolog 2 (SIAH2) downregulation is associated with tamoxifen resistance in MCF-7 breast cancer cells.Mechanisms of synergism between antagonists of growth hormone-releasing hormone and antagonists of luteinizing hormone-releasing hormone in shrinking experimental benign prostatic hyperplasia.Germline genetic variation modulates tumor progression and metastasis in a mouse model of neuroendocrine prostate carcinoma.Wnt/β-catenin activation promotes prostate tumor progression in a mouse modelThe ubiquitin ligase Siah is a novel regulator of Zeb1 in breast cancer.Estrogen Receptor β2 Induces Hypoxia Signature of Gene Expression by Stabilizing HIF-1α in Prostate Cancer.Animal models relevant to human prostate carcinogenesis underlining the critical implication of prostatic stem/progenitor cells.The Expression of the Ubiquitin Ligase SIAH2 (Seven In Absentia Homolog 2) Is Increased in Human Lung Cancer.The Steroidogenic Enzyme AKR1C3 Regulates Stability of the Ubiquitin Ligase Siah2 in Prostate Cancer CellsComputational Identification of Key Regulators in Two Different Colorectal Cancer Cell Lines.Salmonella Bacterial Monotherapy Reduces Autochthonous Prostate Tumor Burden in the TRAMP Mouse ModelUbiquitin ligase Siah2 regulates RevErbα degradation and the mammalian circadian clock.Notch signaling modulates hypoxia-induced neuroendocrine differentiation of human prostate cancer cellsRevising the embryonic origin of thyroid C cells in mice and humans.Elevated JMJD1A is a novel predictor for prognosis and a potential therapeutic target for gastric cancer.Downregulation of the Ubiquitin Ligase RNF125 Underlies Resistance of Melanoma Cells to BRAF Inhibitors via JAK1 Deregulation.Targeting epigenetic regulations in cancerA high-fat diet containing whole walnuts (Juglans regia) reduces tumour size and growth along with plasma insulin-like growth factor 1 in the transgenic adenocarcinoma of the mouse prostate model.Regulation of c-Myc expression by the histone demethylase JMJD1A is essential for prostate cancer cell growth and survival.Parkin ubiquitinates Tar-DNA binding protein-43 (TDP-43) and promotes its cytosolic accumulation via interaction with histone deacetylase 6 (HDAC6).
P2860
Q21144915-A4886B11-DEF0-4396-8DD6-564E5F275A97Q21261257-C2F25BBD-8BC7-4CE2-9AFA-17665D3FA7B3Q21560783-B1AD1401-9B50-4ABA-ABB1-2CEF5A0303BBQ24306252-7C138826-C4D4-4773-844C-F4B61B2924E6Q24337119-E408E0DB-6C32-4C09-B248-FCA7B374E2C3Q24629323-CB1197D9-E810-433C-B8F1-EE8E06290D1AQ26859201-2A862643-D121-40EC-8F3A-DE07B4432928Q26992049-0FC1F34D-768A-4F76-8CA4-A977785F197AQ27026768-F69210B5-DDC3-428F-BC49-3E4C73F39B5AQ27679208-234E86B1-C25A-4D10-829F-0233818F8401Q28068146-1B88CF75-4956-49E7-9749-1F988E3B8432Q28073470-8A7C06A4-EFFC-4759-8B20-BB52D54F4543Q28539588-00747E49-3492-4B05-B609-9F493CDD29F3Q33583668-5C1D1938-4B82-44FF-A179-E0B12145CB32Q33623369-EADE4C1F-2897-4F17-A321-A5BEAFC53432Q33688385-C32234A1-DB86-48FF-9BA6-49A8C1EA7EC5Q33940867-B595B1FF-5AC1-46E1-ACF5-CDC17A6BCEA8Q34155908-248417E4-3BFD-488E-BB18-9A613A88C30EQ34365632-C44AAB52-5FEC-4284-B852-38369C992237Q34383988-5993354D-B9FB-4443-8C21-145F0B833B42Q34431899-777A6D2C-B971-4955-8BCE-0C65E5560226Q34529072-F5D50CFF-35FB-4D4E-B467-C7F53B82840FQ34689297-CBB1658E-3E15-4F46-9907-433131DD43F2Q34842686-ADE3C32D-B4FF-4BEB-BC2A-2925BBD0F03FQ35176165-B54B18A4-C7EA-4723-A40B-6B822DE8B26CQ35641661-22728D54-2A38-4B34-8D7C-EF6A21899486Q35746535-7F4D9218-4268-40D0-B624-DBA5933ED0F3Q35845192-6D8B2498-C538-4162-98B6-4E19FDC79397Q35978237-139E118C-1970-4716-9CB3-E753117BDB92Q35993392-389ADF78-93D0-49C9-A7EC-E334124A01DAQ36098726-486EC6CC-70F6-4D52-AEC1-14FAF986D725Q36155380-CF9B7464-64F6-476E-B46C-BB2F5C2868E2Q36206248-40A37E68-45BA-4A23-B610-835595960385Q36245113-6AAB376A-661A-4B72-9E96-64DD354E8F70Q36261640-AA354418-A99C-47E4-9304-00912A6B0AF4Q36377576-E1FD864D-F232-44E7-BAB6-B7F681DFA893Q36398751-2C3BE641-3DBA-41A6-880D-CAA8188689DAQ36443123-9A092937-570D-4D3E-99D4-9D6CEABFACBCQ36590632-9A459AB0-D447-4E05-BAF3-1FAB354657E6Q36596241-F461F294-E996-4CAE-964E-32D5568D15F4
P2860
Siah2-dependent concerted activity of HIF and FoxA2 regulates formation of neuroendocrine phenotype and neuroendocrine prostate tumors
description
2010 nî lūn-bûn
@nan
2010 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Siah2-dependent concerted acti ...... neuroendocrine prostate tumors
@ast
Siah2-dependent concerted acti ...... neuroendocrine prostate tumors
@en
Siah2-dependent concerted acti ...... neuroendocrine prostate tumors
@en-gb
Siah2-dependent concerted acti ...... neuroendocrine prostate tumors
@nl
type
label
Siah2-dependent concerted acti ...... neuroendocrine prostate tumors
@ast
Siah2-dependent concerted acti ...... neuroendocrine prostate tumors
@en
Siah2-dependent concerted acti ...... neuroendocrine prostate tumors
@en-gb
Siah2-dependent concerted acti ...... neuroendocrine prostate tumors
@nl
prefLabel
Siah2-dependent concerted acti ...... neuroendocrine prostate tumors
@ast
Siah2-dependent concerted acti ...... neuroendocrine prostate tumors
@en
Siah2-dependent concerted acti ...... neuroendocrine prostate tumors
@en-gb
Siah2-dependent concerted acti ...... neuroendocrine prostate tumors
@nl
P2093
P2860
P50
P921
P3181
P1433
P1476
Siah2-dependent concerted acti ...... neuroendocrine prostate tumors
@en
P2093
Alexander D Borowsky
Dan Mercola
Karen Kaul
Koh Nakayama
Philip M Carpenter
Robert D Cardiff
Roy Williams
Stan Krajewski
P2860
P3181
P356
10.1016/J.CCR.2010.05.024
P407
P577
2010-07-01T00:00:00Z